EHSI expects new iPhone 4.0 OS to benefit MedAnywhere application

Emerging Healthcare Solutions, Inc. (Pink Sheets: EHSI) enthusiastically welcomed a highly anticipated report that Apple has unveiled the new iPhone 4.0 Operating System, which the Company believes will greatly benefit the MedAnywhere medical app currently in development. Specifically, new multitasking ability can be applied so that a physician can initiate patient monitoring subroutines without having to exit the MedAnywhere live communications portal. The Company expects this upgrade to bolster the MedAnywhere application's advanced flexibility in the remote and mobile medical treatment arenas.

According to Apple's CEO Steve Jobs, the previous version of the iPhone's Operating System is installed in 85 million devices, including more than 50 million iPhones. This year, the total will surpass 100 million. The upgraded 4.0 software will be available for the iPhone and the iTouch around midyear, and for the iPad in September.

There is widespread speculation that new iPhone hardware also will be introduced around the time Apple makes the new iPhone software available. EHSI is monitoring this development very closely as it anticipates new equipment options to be made available for integration by the MedAnywhere application development team.

More information about the cutting edge app can be seen at: www.emerginghealthcaresolutionsinc.com/medanywhere.php

Consumers spent $2.4 Billion last year purchasing iPhone apps - a number that is expected to triple in the next three years. With 34 Million iPhone users currently connected to the system, the Company believes the MedAnywhere application could revolutionize the way patients interact with doctors and hospitals across America and around the world - including drastically lowering medical costs for the app subscriber.

EHSI took the lead in the new mobile Telemedicine industry through their prior licensing and development of an extraordinary ambulance trauma communications platform. This system was originally the brainchild of Dr. Red Duke and was funded through a $20 million US Department of Defense grant to the University of Texas Health Sciences Center at Houston. UT then engaged Texas A&M to fully develop the system.

iPhone is a portable data device produced by Apple, Inc. (NASDAQ: AAPL). It allows users to download and operate 'applications' that empower the portable device to deliver a wide variety of additional services. The iPhone competes with Google, Inc's (NASDAQ: GOOG) Android system and with Research-in-Motion's (NASDAQ: RIMM) Blackberry phones. The emerging medical technology sector also includes Gilead Sciences (NASDAQ: GILD).